Johnson & Johnson vs STERIS plc
JNJ vs STE — side-by-side comparison from reported financials. JNJ leads 6, STE leads 4 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
STERIS plc
STE · Healthcare
$214.40+1.73%Strong
| Metric | JNJ | STE |
|---|---|---|
| Price | $261.79 | $214.40 |
| Market cap | $631B | $20.9B |
| Revenue (TTM) | $97.9B | $6.04B |
| Revenue growth | +5.6% | +6.2% |
| Net margin | 21.5% | 13.3% |
| Free cash flow | $22.2B | $926M |
| Net cash (debt) | ($27.8B) | ($1.65B) |
| 1-year price return | +37.0% | -10.5% |
| P/E | 29.9 | 26.0 |
| P/E vs own history (cheap-side %) | 16% | 97% |
| Dividend yield | 2.00% | 1.18% |
| Return on equity | 26% | 11% |
| Altman Z-score | — | 4.34 |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 140,800 | 17,937 |
Full résumé-style profiles: JNJ CV · STE CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.